U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07287943) titled 'To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.' on Dec. 14.

Brief Summary: The goal of this clinical trial is to learn if Medtronic 780G automated insulin delivery system improves high blood sugars in adult persons with type 1 diabetes and gastroparesis. It will also learn about the safety of this system. Main questions it aims to answer are:

Does Medtronic 780G automated insulin delivery system (insulin pump) improve blood glucose in range from start of study to 3months.

Researchers will compare Medtronic 780G automated insulin delivery system with usual care (mul...